Entrada Therapeutics Inc (TRDA)

Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.78%0.91	0.90	0.88	1.30	1.61
	7.12%42.59	45.86	43.18	43.51	48.67
Research and Development	8.48%32.37	35.37	33.05	33.96	38.36
Operating Income/Loss	7.28%-41.69	-44.96	-42.30	-42.21	-47.05
Income Tax Expense/Benefit	22.86%0.03	0.04	0.04	0.09	0.65
	7.06%-39.74	-42.76	-39.72	-39.16	-44.13
Attributable To Parent	7.06%-39.74	-42.76	-39.72	-39.16	-44.13
Basic Average Shares	0.36%42.37	42.22	41.84	0.08	41.46
Diluted Average Shares	0.36%42.37	42.22	41.84	0.08	41.46
Basic Earnings Per Share	6.93%-0.94	-1.01	-0.95	-0.94	-1.06
Diluted Earnings Per Share	6.93%-0.94	-1.01	-0.95	-0.94	-1.06